NAMPA: FDA Reaffirms That Current Uses Of BPA Pose No Risk; Calls For More BPA Research
The North American Metal Packaging Alliance, Inc. (NAMPA) supports the U.S. Food and Drug Administration’s (FDA) announcement today to continue its ongoing scientific research and evaluation of bisphenol A (BPA). At the same time, FDA officials reiterated that consumers can continue to use safely existing products that contain BPA. The FDA announcement clearly noted that BPA exposure is not proven to harm children or adults which is consistent with other international regulatory bodies.
For the full story, Click Here
- Report says greens can also pose health risk
- Research On Tamoxifen Leads To Recommendation For CYP2D6 Gene Test
- Study links chocolate to low heart failure risk
- FDA 510(k) clearance to Baxter’s Anti-Pathogen technology
